Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg
#1PRI RANKED
Most Cited Paper
in Neonatal Respiratory Health Research
18 Months Post-Publication
Class of 2026
“Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/neonatal-respiratory-health-research/2026/
Topics
nirsevimab · Respiratory syncytial virus (RSV) · RSV hospitalization · Infant immunization · Infants under 6 months · paediatric intensive care unit admissions · Length of stay · Severe RSV disease · prophylaxis effectiveness · RSV season · Luxembourg healthcare system · age distribution of hospitalised children · RSV immunization program
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Neonatal Respiratory Health Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/neonatal-respiratory-health-research/2026. Accessed 2026-07-22. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459